ORACEA caps ret 40 mg 28 pce

7680616860019 CH-61686 J01AA02 08.01.5.

Reimbursement limitations:

ORACEA

Prescription initiale par un dermatologue uniquement. Les traitements suivants peuvent être effectués par un médecin …

ORACEA caps ret 40 mg 28 pce
ORACEA caps ret 40 mg 28 pce
ORACEA caps ret 40 mg 28 pce
1 / 3
google

Details

Product number
6168601
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
doxycyclinum 40 mg ut doxycyclinum monohydricum 41.62 mg, sacchari sphaerae corresp. maydis amylum et saccharum 150.36 mg, hypromellosum, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, talcum, hypromellosum, macrogolum 400, polysorbatum 80, E 171, E 172 (flavum), E 172 (rubrum), Kapselhülle: gelatina, E 171, E 172 (nigrum), E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, E 132, E 129, E 133, E 104, pro capsula.

Articles (1)

Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung
Hartkapseln mit veränderter Wirkstofffreisetzung
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
31/12/2021
Patient information leaflet
Français
31/12/2021
Patient information leaflet
Italien
31/12/2021
Professional SmPC
Allemand
30/06/2021
Professional SmPC
Français
30/06/2021
Professional SmPC
Italien
30/06/2021

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
41.62 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
150.36 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FIMDK
(N/A)
- Substance HBESI
(N/A)
- Substance FIMDK
(N/A)
- Substance FIMDK

Reimbursement information

Public price
CHF 33.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2013

Authorization holder

Galderma SA

6300 Zug

Authorization information

Swissmedic authorization number
61686
Drug name
Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung
Galenic form
KAHA
ATC Code
J01AA02
Authorization status
Z
Dispensation category
A
First authorization
15/03/2012
Authorization expiration date
31/12/9999
IT number
08.01.5.
Domain
Human medicine
Field of application
Rosazea

Packaging details

Description (FR)
ORACEA caps ret 40 mg 28 pce
Description (DE)
ORACEA Ret Kaps 40 mg 28 Stk
Market launch
15/03/2012
Narcotic (BTM)
No

Available generics

Doxyclin, Tabletten
CHF 13.35
View
Doxyclin, Tabletten
CHF 31.85
View
Doxyclin, Tabletten
CHF 16.45
View
Doxycyclin-Mepha, Tabletten
CHF 25.55
View
Doxycyclin-Mepha, Tabletten
CHF 14.15
View
Doxycyclin-Mepha, Tabletten
CHF 17.60
View
Doxylag 100, capsules
CHF 14.25
View
Doxylag 100, capsules
CHF 38.60
View
Doxylag 100, capsules
CHF 13.30
View
Doxysol, Tabletten
CHF 13.30
View

Other packaging sizes

ORACEA caps ret 40 mg 56 pce
56 KAP
View